Salud financiera de hoja de balance de PCC Rokita

Salud financiera controles de criterios 6/6

PCC Rokita tiene un patrimonio de accionistas total de PLN1.4B y una deuda total de PLN523.4M, lo que sitúa su ratio deuda-patrimonio en 37.9%. Sus activos y pasivos totales son PLN2.5B y PLN1.1B respectivamente. El BAIT de PCC Rokita es de PLN378.4M, por lo que su ratio de cobertura de intereses es de 20.1. Tiene efectivo e inversiones a corto plazo que ascienden a PLN290.4M.

Información clave

37.9%

Ratio deuda-patrimonio

zł523.38m

Deuda

Ratio de cobertura de intereses20.1x
Efectivozł290.41m
Patrimoniozł1.38b
Total pasivozł1.14b
Activos totaleszł2.52b

Actualizaciones recientes sobre salud financiera

Recent updates

Is PCC Rokita (WSE:PCR) Using Too Much Debt?

Aug 24
Is PCC Rokita (WSE:PCR) Using Too Much Debt?

PCC Rokita's (WSE:PCR) Shareholders Will Receive A Bigger Dividend Than Last Year

Apr 29
PCC Rokita's (WSE:PCR) Shareholders Will Receive A Bigger Dividend Than Last Year

Is PCC Rokita (WSE:PCR) A Risky Investment?

Jan 18
Is PCC Rokita (WSE:PCR) A Risky Investment?

PCC Rokita (WSE:PCR) Is Increasing Its Dividend To zł13.23

Apr 16
PCC Rokita (WSE:PCR) Is Increasing Its Dividend To zł13.23

Why We Like The Returns At PCC Rokita (WSE:PCR)

Mar 19
Why We Like The Returns At PCC Rokita (WSE:PCR)

What Is PCC Rokita SA's (WSE:PCR) Share Price Doing?

Jan 25
What Is PCC Rokita SA's (WSE:PCR) Share Price Doing?

We Like These Underlying Return On Capital Trends At PCC Rokita (WSE:PCR)

Sep 01
We Like These Underlying Return On Capital Trends At PCC Rokita (WSE:PCR)

Why PCC Rokita SA (WSE:PCR) Could Be Worth Watching

Jun 14
Why PCC Rokita SA (WSE:PCR) Could Be Worth Watching

Are PCC Rokita SA (WSE:PCR) Investors Paying Above The Intrinsic Value?

May 18
Are PCC Rokita SA (WSE:PCR) Investors Paying Above The Intrinsic Value?

Returns On Capital At PCC Rokita (WSE:PCR) Have Hit The Brakes

Apr 13
Returns On Capital At PCC Rokita (WSE:PCR) Have Hit The Brakes

Why PCC Rokita's (WSE:PCR) Earnings Are Better Than They Seem

Mar 23
Why PCC Rokita's (WSE:PCR) Earnings Are Better Than They Seem

PCC Rokita SA's (WSE:PCR) Has Been On A Rise But Financial Prospects Look Weak: Is The Stock Overpriced?

Mar 09
PCC Rokita SA's (WSE:PCR) Has Been On A Rise But Financial Prospects Look Weak: Is The Stock Overpriced?

Looking For Steady Income For Your Dividend Portfolio? Is PCC Rokita SA (WSE:PCR) A Good Fit?

Feb 19
Looking For Steady Income For Your Dividend Portfolio? Is PCC Rokita SA (WSE:PCR) A Good Fit?

What Does PCC Rokita SA's (WSE:PCR) Share Price Indicate?

Feb 04
What Does PCC Rokita SA's (WSE:PCR) Share Price Indicate?

Is PCC Rokita (WSE:PCR) Using Too Much Debt?

Jan 15
Is PCC Rokita (WSE:PCR) Using Too Much Debt?

Should We Be Excited About The Trends Of Returns At PCC Rokita (WSE:PCR)?

Dec 30
Should We Be Excited About The Trends Of Returns At PCC Rokita (WSE:PCR)?

Reflecting on PCC Rokita's (WSE:PCR) Share Price Returns Over The Last Three Years

Dec 17
Reflecting on PCC Rokita's (WSE:PCR) Share Price Returns Over The Last Three Years

PCC Rokita SA's (WSE:PCR) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?

Dec 03
PCC Rokita SA's (WSE:PCR) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?

Are Dividend Investors Getting More Than They Bargained For With PCC Rokita SA's (WSE:PCR) Dividend?

Nov 20
Are Dividend Investors Getting More Than They Bargained For With PCC Rokita SA's (WSE:PCR) Dividend?

Análisis de la situación financiera

Pasivos a corto plazo: Los activos a corto plazo (PLN797.2M) de PCR superan a sus pasivos a corto plazo (PLN502.2M).

Pasivo a largo plazo: Los activos a corto plazo de PCR (PLN797.2M) superan a sus pasivos a largo plazo (PLN641.3M).


Historial y análisis de deuda-patrimonio

Nivel de deuda: El ratio deuda neta-patrimonio (16.9%) de PCR se considera satisfactorio.

Reducción de la deuda: El ratio deuda-patrimonio de PCR ha pasado de 76.5% a 37.9% en los últimos 5 años.

Cobertura de la deuda: La deuda de PCR está bien cubierta por el flujo de caja operativo (97.8%).

Cobertura de intereses: Los pagos de intereses de la deuda de PCR están bien cubiertos por el BAIT (20.1x cobertura).


Hoja de balance


Descubre empresas con salud financiera